Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response

Abstract:
Having funded $2 million total to support 27 high-risk, high-reward approaches to Parkinson's disease research in the first year of its Rapid Response Innovation Awards (RRIA) initiative, The Michael J. Fox Foundation today announced that it will commit $2 million to a second round of funding in 2008. RRIA is designed to ensure that researchers can pursue good ideas without delay. Under this program the Foundation accepts proposals on a rolling basis with no deadline, makes funding decisions within six weeks of application and speeds up to $75,000 to one-year basic, preclinical or clinical research projects in any Parkinson's-relevant arena.

Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response

New York, NY | Posted on December 12th, 2007

"RRIA funds 'flashes of insight' in real time, hopefully helping to open new avenues for PD therapy development," said Katie Hood, interim CEO of The Michael J. Fox Foundation.

To accommodate these "flashes of insight," the program's criteria and application process are designed with novelty and speed in mind.

Todd Sherer, PhD, vice president of research programs at MJFF, said: "We set up RRIA to attract new researchers to Parkinson's and to provide support for unorthodox ideas -- the sort that could significantly impact PD treatment, but that may have little or no preliminary data, making it hard or impossible to find traditional funding to carry them out. Based on the strong response from the scientific community in 2007, it's clear this program is filling a need."

The program is designed to provide funding for strong ideas being tested for the first time. Unlike other Foundation initiatives, RRIA allows for the submission of applications at any time of year. There is no pre-proposal stage, and the standard application has been shortened to three pages. Additionally, postdoctoral researchers are permitted to apply as principal investigators under this initiative provided the head of their lab serves as Administrative PI to assist with the provision of institutional documents and sign the award contract.

Projects funded in 2008 include: -- A project testing whether isradipine, a high-blood-pressure drug already approved for use in humans, protects dopamine neurons in an animal model of Parkinson's disease; -- Development of nanoparticle technology as a non-viral gene therapy technique that could help overcome the delivery challenges of getting PD therapeutics past the blood-brain barrier; -- A project to test the Braak Hypothesis, which posits that sporadic Parkinson's may begin not in the central nervous system but in the enteric, or gastrointestinal, nervous system -- knowledge that would provide revolutionary insights into the pathogenesis and progression of PD; and -- Initial work to determine whether low levels of a gene called ST13 predict risk of future PD (which could lead to the development of a practical, widely available blood test for early and objective diagnosis of Parkinson's disease).

A complete list of projects funded under RRIA 2007, including researcher bios and grant abstracts, is available at http://www.michaeljfox.org/.

####

About Michael J. Fox Foundation for Parkinson's Research
Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded $100 million in research to date.

For more information, please click here

Contacts:
The Michael J. Fox Foundation for Parkinson's Research
Church Street Station
P.O. Box 780
New York, NY 10008-0780
1-800-708-7644

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Do titanium dioxide particles from orthopedic implants disrupt bone repair? September 16th, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Graphene based terahertz absorbers: Printable graphene inks enable ultrafast lasers in the terahertz range September 13th, 2017

Applications for the nanomedTAB are open until September 18th, 2017 September 13th, 2017

Announcements

Quantum twisted Loong confirms the physical reality of wavefunctions September 23rd, 2017

Application of air-sensitive semiconductors in nanoelectronics: 2-D semiconductor gallium selenide in encapsulated nanoelectronic devices September 22nd, 2017

Researchers set time limit for ultrafast perovskite solar cells September 22nd, 2017

DNA triggers shape-shifting in hydrogels, opening a new way to make 'soft robots' September 21st, 2017

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

Magnetic cellular 'Legos' for the regenerative medicine of the future September 12th, 2017

Quantum detectives in the hunt for the world's first quantum computer September 8th, 2017

New results reveal high tunability of 2-D material: Berkeley Lab-led team also provides most precise band gap measurement yet for hotly studied monolayer moly sulfide August 26th, 2017

A more complete picture of the nano world August 24th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project